Latest Breaking News On - Tuhura biosciences inc - Page 1 : comparemela.com

Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results

Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoRoberte hoffmanTuhura biosciences incNasdaq stock marketUs securities exchange commissionKayak mergeco incExchange commissionNational institutes of healthKintara therapeutics incSmall business innovation researchKintara therapeuticsKayak mergecoMerger agreementBest overall objective response rateNational institutes

Kintara Therapeutics : TuHURA Biosciences to Present Its IFx-2 0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - Form 8-K

TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology Annual Meeting TAMPA, FL&SAN.

United statesSan diegoJenene thomasAndrew brohlRoberte hoffmanTuhura biosciences incH lee moffitt cancer centerAmerican society of clinical oncologyKintara therapeutics incExchange commissionResearch institutePresent itsCancer vaccine clinical trial resultsClinical oncologyAnnual meetingMerkel cell carcinoma

TuHURA Biosciences to Present Its IFx-2 0 Personalized Cancer Vaccine

TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine .

United statesSan diegoAndrew brohlNews networkH lee moffitt cancer centerTuhura biosciences incExchange commissionKintara therapeutics incResearch institute session titleMerkel cell carcinomaCutaneous squamous cell carcinomaMoffitt cancer centerSkin cancers session dateKintara therapeuticsAntibody drug conjugatesNasdaq capital market

TuHURA Biosciences to Present Its IFx-2 0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

TuHURA Biosciences to Present Its IFx-2 0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoJenene thomasRoberte hoffmanAndrew brohlExchange commissionMorphogenesis incKintara therapeutics incH lee moffitt cancer centerResearch instituteTuhura biosciences incMerkel cell carcinomaCutaneous squamous cell carcinomaMoffitt cancer centerKintara therapeuticsAntibody drug conjugates

Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement

Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoJames biancoRoberte hoffmanDan dearbornJenene thomasKintara therapeutics incLowenstein sandlerExchange commissionManagement organizationHc wainwright coTuhura biosciences incLucid capital marketsFoley lardnerApproval programAntibody drug conjugates